MPP1 mRNA level has been reported to be decreased in two atypical parkinsonian disorders (multiple system atrophy (MSA) and progressive supranuclear palsy (PSP)) and PD compared with healthy controls. The gene discussed is MPP1; the disease is progressive supranuclear palsy.